Stimcell Energetics (STME) Net Income (QoQ) (2016 - 2024)
Stimcell Energetics (STME) Net Income (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -85.00% |
| Feb 29, 2024 | -11.56% |
| Nov 30, 2023 | 21.32% |
| Aug 31, 2023 | 3.06% |
| May 31, 2023 | 32.82% |
| Feb 28, 2023 | 17.26% |
| Nov 30, 2022 | 7.67% |
| Aug 31, 2022 | 4.84% |
| May 31, 2022 | -36.05% |
| Feb 28, 2022 | 32.10% |
| Nov 30, 2021 | 26.48% |
| Aug 31, 2021 | -27.57% |
| May 31, 2021 | -4.82% |
| Feb 28, 2021 | 5.45% |
| Nov 30, 2020 | 5.90% |
| Aug 31, 2020 | 20.10% |
| May 31, 2020 | 29.33% |
| Feb 29, 2020 | -17.41% |
| Nov 30, 2019 | -23.73% |
| Aug 31, 2019 | 79.45% |